HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The tylosis esophageal cancer (TOC) locus: more than just a familial cancer gene.

Abstract
Tylosis (focal non-epidermolytic palmoplantar keratoderma; NEPPK) is associated with esophageal cancer in three families, two of which contain six or seven generations. The causative locus, the tylosis esophageal cancer (TOC) gene, has been localized to a small region on chromosome 17q25. Recent loss of heterozygosity (LOH) studies have indicated a role for the TOC gene in sporadic squamous cell esophageal cancer and Barrett's adenocarcinoma. We have now integrated genetic and physical mapping data from the TOC region, based on microsatellite markers and radiation hybrid, yeast (YAC), bacterial (BAC) and P1 artificial chromosomal (PAC) clones, and formed a partial minimal contig of one non-chimeric YAC (330 kb) and one PAC. Twenty-three candidate genes, including envoplakin (EVPL), were mapped against this contig, but only one was shown to be located within the minimal region. This physical map will allow further characterization of the region and identification of a gene implicated in both familial and sporadic squamous cell esophageal carcinoma and Barrett's adenocarcinoma.
AuthorsJ M Risk, H S Mills, J Garde, J R Dunn, K E Evans, M Hollstein, J K Field
JournalDiseases of the esophagus : official journal of the International Society for Diseases of the Esophagus (Dis Esophagus) Vol. 12 Issue 3 Pg. 173-6 ( 1999) ISSN: 1120-8694 [Print] United States
PMID10631907 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Barrett Esophagus (genetics)
  • Carcinoma, Squamous Cell (genetics)
  • Chromosome Mapping
  • Chromosomes, Human, Pair 17 (genetics)
  • Contig Mapping
  • Esophageal Neoplasms (genetics)
  • Genetic Linkage
  • Haplotypes
  • Humans
  • Keratoderma, Palmoplantar, Diffuse (genetics)
  • Loss of Heterozygosity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: